Association between inflammation and biological variation in hemoglobin A1c in U.S. nondiabetic adults

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages 2364-2371

  Liu, Shuqian ^a,b   Hempe, James M ^c   McCarter, Robert J ^d   Li, Shengxu ^a,b   Fonseca, Vivian A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLACK PERSON; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CAUCASIAN; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN ANALYSIS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; METABOLIC REGULATION; MONOCYTE; NEUTROPHIL; OBESITY; PRIORITY JOURNAL; RISK FACTOR; UNDERWEIGHT; UNITED STATES; WAIST CIRCUMFERENCE; BLOOD; BLOOD CELL COUNT; CYTOLOGY; EPIDEMIOLOGY; GLYCOSYLATION; HEALTH STATUS INDICATOR; METABOLISM; MIDDLE AGED; NUTRITION;

ADULT; BLOOD CELL COUNT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; GLYCOSYLATION; HEALTH STATUS INDICATORS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES; NUTRITION SURVEYS; UNITED STATES;

EID: 84930801049     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4454     Document Type: Article

References (44)

1. Kamps JL, Hempe JM, Chalew SA. Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care. 2010;33:1025-1027.
2. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: An analysis of data from the Diabetes Control and Complications Trial. Diabetes Care. 2006;29:352-325.
3. Wilson DM, Xing D, Cheng J, et al. Persistence of individual variations in glycated hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care. 2011;34:1315-1317.
4. Hempe JM, Soros AA, Chalew SA. Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control. Diabetes Care. 2010;33:1449-1451.
5. Chalew S, Hempe JM. Caveats regarding the use of HbA1c for prediction of mean blood glucose. Diabetologia. 2008;51:903-904; author reply 905-906.
6. Chalew SA, Hempe JM, McCarter R. Clinically significant disagreement between mean blood glucose and estimated average glucose in two populations: Implications for diabetes management. J Diabetes Sci Technol. 2009;3:1128-1135.
7. Hempe JM, Ory-Ascani J. Simultaneous analysis of reduced glutathione and glutathione disulfide by capillary zone electrophoresis. Electrophoresis. 2014;35:967-971.
8. Hempe JM, McGehee AM, Hsia D, Chalew SA. Characterization of unstable hemoglobin A1c complexes by dynamic capillary isoelectric focusing. Anal Biochem. 2012;424:149-155.
9. Chalew SA, McCarter RJ, Ory-Ascani J, Hempe JM. Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes. Diabetes Care. 2010;33:273-274.
10. Somjee S, Yu LC, Hagar AF, Hempe JM. Diagnosis and characterization of Hb C/Hb Iowa: A rare but easily misidentified compound heterozygous condition. Hemoglobin. 2004;28:7-13.
11. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313-320.
12. Chalew SA, McCarter RJ, Hempe JM. Biological variation and hemoglobin A1c: Relevance to diabetes management and complications. Pediatr Diabetes. 2013;14:391-398.
13. Hempe JM, McCarter RJ, Chalew SA. Comment on: Wilson et al. Persistence of individual variations in glycated hemoglobin: analysis of data from the juvenile diabetes research foundation continuous glucose monitoring randomized trial. Diabetes Care. 2011;34:e170; author's reply e171.
14. Shurtz-Swirski R, Sela S, Herskovits AT, et al. involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care. 2001;24:104-110.
15. Gustavsson CG, Agardh CD. Inflammatory activity increases with haemoglobin A1c in patients with acute coronary syndrome. Scand Cardiovasc J. 2009;43:380-385.
16. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and c-reacting protein. Hypertension. 2002;39:777-780.
17. Jiang H, Yan WH, Li CJ, Wang AP, Dou JT, Mu YM. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health. 2014;11:5497-5509.
18. Tsai JCR, Sheu SH, Chiu HC, et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2007;23:111-118.
19. Zozulinska D, Wierusz-Wysocka B. Type 2 diabetes mellitus as inflammatory disease. Diabetes Res Clin Pract. 2006;74:S12-S16.
20. Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2002;155:65-71.
21. Gustavsson CG, Agardh CD. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur Heart J. 2004;25:2120-2124.
22. Farah R, Shurtz-Swirski R, Lapin O. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol. 2008;7:20.
23. Soros AA, Chalew SA, McCarter RJ, Shepard R, Hempe JM. Hemoglobin glycation index: A robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11:455-461.
24. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27:1259-1264.
25. Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca VA. The hemoglobin glycation index identifies subpopulations with harms or benefits in the ACCORD trial. Published online ahead of print April 17, 2015. DOI: 10.2337/dc14-1844.
26. Curtin LR, Mohadjer LK, Dohrmann SM, et al. The National health and nutrition examination survey: Sample design, 1999-2006. National Center for Health Statistics. Vital Health Stat. 2013;(2)1-39.
27. Cheng YJ, Kahn HS, Gregg EW, Imperatore G, Geiss LS. Recent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis. Diabetologia. 2010;53:1890-1893.
28. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010;2:180-193.
29. National Health and Nutrition Examination Survey. http://wwwcdcgov/nchs/nhanes/nhanes-questionnaireshtm.
30. George-Gay B, Parker K. Understanding the complete blood count with differential. J Perianesth Nurs. 2003;18:96-117; quiz 115-117.
31. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
32. Chalew SA, McCarter RJ, Thomas J, Thomson JL, Hempe JM. A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes. J Diabetes Complications. 2005;19:218-222.
33. Thorand B, Löwel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: Results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med. 2003;163:93-99.
34. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183-191.
35. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007;378:48-52.
36. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
37. Sultana GS, Haque SA, Sultana T, Ahmed AN. Value of red cell distribution width (RDW) and RBC indices in the detection of iron deficiency anemia. Mymensingh Med J. 2013;22(2):370-376.
38. Ahmad J, Rafat D. HbA1c and iron deficiency: A review. Diabetes Metab Syndr. 2013;7(2):118-122.
39. Engström G, Smith JG, Persson M, Nilsson PM, Melander O, Hedblad B. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med. 2014;276(2):174-183.
40. Veeranna V, Zalawadiya SK, Panaich SS, Ramesh K, Afonso L. The association of red cell distribution width with glycated hemoglobin among healthy adults without diabetes mellitus. Cardiology. 2012;122(2):129-132.
41. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628-632.
42. Vaya A, Hernández JL, Zorio E, Bautista D. Association between red blood cell distribution width and the risk of future cardiovascular events. Clin Hemorheol Microcirc. 2012;50(3):221-225.
43. Tziakas D, Chalikias G, Grapsa A, Gioka T, Tentes I, Konstantinides S. Red blood cell distribution width: A strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte membrane. Clin Hemorheol Microcirc. 2012;51(4):243-254.
44. Updated Advisory for NHANES Hemoglobin A1c (Glycohemoglobin) Data. (revised March 2012). http://wwwcdcgov/nchs/data/nhanes/A1c-webnoticepdf.